
Credit: Unsplash/CC0 Public Domain
The new study by the University of Exeter, published in Cell Host Microbe, has cast new light on how to best combine antibiotics and phage therapy
New research has moved a step closer to harnessing viruses to fight bacterial infection, reducing the threat of antibiotic resistance.
A growing number of infections, including pneumonia, tuberculosis, gonorrhoea, and salmonellosis, are developing antibiotic resistance, which means they becoming harder to treat, resulting in higher death rates, longer hospital stays and higher costs.
Phage therapy is the concept of using viruses (known as phage) that are harmless to humans to kill bacteria. Phage therapy can be used in combination with antibiotics to cure infections more effectively, and reduce the opportunity for bacteria to develop antibiotic resistance. However, bacteria can also evolve resistance to phages.
The new study by the University of Exeter, published in Cell Host Microbe, has cast new light on how to best combine antibiotics and phage therapy. Researchers conducted laboratory experiments on Pseudomonas aeruginosa a bacterium which causes disease in immunocompromised and cystic fibrosis patients. They exposed the bacterium to eight types of antibiotics – and found differences in the mechanisms by which the bacteria evolve resistance to phages, which affect how harmful they are.
Viruses penetrate molecules on the cell surface to infect bacteria. Like the human immune system, bacteria have their own CRISPR defence system, made up of proteins that fight off infection. As in human immune responses, this means that the virus infects the bacteria, and is then killed. In the process, the bacteria’s CRISPR system learns to recognise and attack the virus in future.
However, the bacteria have a second defence option. They can also change their own cell surface to ward off infection, losing the receptor to which phages normally attach. This option comes with a cost to bacteria – the bacteria become less virulent, meaning they no longer cause disease, or the disease becomes less severe.
In the study, four of the eight antibiotics tested caused a dramatic increase in the levels of CRISPR-based immunity. These antibiotics are all bacteriostatic – they do not directly kill cells but act by slowing down cell growth.
Professor Edze Westra, of the University of Exeter, said; “Antibiotic resistance is a major public health issue, and we need to take swift and urgent action. Phage therapy could be an important part of the toolkit, in reducing antibiotic use, and in using them in combination to increase their efficiency. We found that by changing the type of antibiotics that are used in combination with phage, we can manipulate how bacteria evolve phage resistance, increasing the chances that treatment is effective. These effects should be considered during phage-antibiotic combination therapy, given their important consequences for pathogen virulence.”
Phage therapy was first used in 1919, when Parisian microbiologist Félix d’Hérelle gave a phage cocktail to a 12-year-old boy, apparently curing his severe dysentery. Yet despite early promise, research dried up in the 40s as the world began to adopt the quick medical fix of antibiotics.
Now, research is again gathering momentum as part of the solution to reduce antibiotic resistance. Although a promising alternative with some remarkable case studies of phage therapy working in individuals, one obstacle to wider use is that bacteria can rapidly evolve resistance to phages, via CRISPR-Cas immunity or via modification of their surface.
The researchers show that the effect of bacteriostatic antibiotics triggering CRISPR-Cas immunity results from slower phage replication inside the cell, which provides more time for the CRISPR-Cas system to acquire immunity and clear the phage infection. The research therefore identifies the speed of phage replication as a crucial factor controlling the possibility for CRISPR-Cas systems to defend against viruses.
Lead author Dr Tatiana Dimitiru, of the University of Exeter, said: This study provides fundamental insight into the constraints of CRISPR immune systems in the face of viruses. It was recently discovered that many CRISPR-Cas immune systems are associated to cell responses that make bacteria slow or stop growth upon phage infection, and we speculate that this may be important for cells to trigger an effective immune response.
Original Article: New research moves closer to harnessing viruses to fight bacteria and reduce antibiotic use
More from: University of Exeter
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Combining antibiotics and phage therapy
- Old cure revived to help fight against antibiotic-resistant superbugs
The Alfred hospital in Melbourne has begun using the pioneering phage therapy, which dates back to 1917 and involves utilising harmless viruses, to kill germs in cases where traditional antibiotics ...
- Introducing Yesterday's Phage Therapy in Today's Medicine
which could also be used in combination (synergy) with antibiotics. [60] The coevolutive aspect of the phage–bacterium couplet, which is essential for sustainable phage therapy, is often neglected.
- Phage Cocktails and the Future of Phage Therapy
Nonetheless, there are several challenges that must be addressed prior to widespread adoption of phage ... of phage therapy (Figure 2), as it is thought to best fit a combination of constraints ...
- Are cures for some of the world’s deadliest diseases hiding in our sewers?
Today with few pharmaceutical companies actively developing antibiotics, phage therapy is one of the few ... let alone more advanced drugs or combination antibiotics that are effective against ...
- Atomic structure of a staphylococcal bacteriophage using cryo-electron microscopy
“Picoviruses are rarely found in phage collections and remain understudied and underused for therapeutic applications,” said Hatoum-Aslan, a phage biologist at the University of Illinois. With ...
Go deeper with Google Headlines on:
Combining antibiotics and phage therapy
[google_news title=”” keyword=”combining antibiotics and phage therapy” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Phage therapy
- Old cure revived to help fight against antibiotic-resistant superbugs
The Alfred hospital in Melbourne has begun using the pioneering phage therapy, which dates back to 1917 and involves utilising harmless viruses, to kill germs in cases where traditional antibiotics ...
- Introducing Yesterday's Phage Therapy in Today's Medicine
[70] The Time Frames for Conventional Medicinal Product Development & Marketing (Years) are Not Compatible With a Flexible, Tailor-made & Sustainable Phage Therapy Concept Phage therapy depends ...
- Phage Cocktails and the Future of Phage Therapy
Their potential as antibacterial agents was appreciated almost immediately, with the first 'phage therapy' trials predating Fleming's discovery of penicillin by approximately a decade. In this ...
- Bacteria-eating viruses kill hard-to-stop infections
UCSD infectious disease specialist, Saima Aslam, MBBS, MS explains, “Bacteria definitely are very smart and definitely have multiple ways of overcoming antibiotics that we use to kill them.” Aslam ...
- Hard-to-stop infections killed by bacteria-eating viruses
A bacterial infection occurs when bacteria enter the body, replicate, and cause a reaction. A special type of virus can stop them.
Go deeper with Google Headlines on:
Phage therapy
[google_news title=”” keyword=”phage therapy” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]